This study is a multicenter, prospective, randomized controlled trial designed to evaluate the effectiveness and safety of a multimodal artificial intelligence (AI)-guided postoperative recovery management system in patients after lung cancer surgery. Eligible patients will be enrolled after surgery when their clinical condition is stable and will be randomly assigned to either an AI-guided recovery management group or a usual postoperative care group. Patients in the AI-guided group will receive usual postoperative care plus a multimodal AI-based recovery management system. The system will collect patient-reported symptoms, vital signs, physical activity, respiratory rehabilitation information, recovery-related data, and, when needed, wound or chest-related images or short videos. Based on these data, the system will provide recovery feedback, general nursing advice, respiratory rehabilitation reminders, activity guidance, and risk stratification alerts. For red-flag symptoms or high-risk conditions, the system will advise patients to contact the clinical team or seek medical care. Patients in the usual-care group will receive standard postoperative management after lung cancer surgery and will complete symptom assessments at the same prespecified time points, but they will not receive AI-generated individualized recovery feedback or AI-generated risk alerts. The primary outcome is the number of MDASI-LC-derived target symptom threshold events within 30 days after surgery. Target symptoms include pain, fatigue, disturbed sleep, shortness of breath, and cough. Secondary outcomes include overall target symptom burden, quality of recovery, time to recovery to a mild-symptom state, functional interference, respiratory rehabilitation adherence, physical activity adherence, unplanned healthcare utilization, pulmonary complications, and unplanned readmission.
Patients recovering from lung cancer surgery commonly experience postoperative symptoms such as pain, cough, shortness of breath, fatigue, disturbed sleep, reduced physical activity, and anxiety. These symptoms may affect recovery experience, daily function, adherence to respiratory rehabilitation, and timely initiation of subsequent anticancer treatment. Conventional postoperative management usually relies on inpatient nursing care, discharge education, scheduled outpatient follow-up, and patient-initiated contact with healthcare professionals. However, symptoms can change rapidly during the early postoperative period and after discharge, and conventional follow-up may not provide continuous and individualized identification of symptom burden, recovery needs, or potential risks. This trial will evaluate whether a multimodal AI-guided postoperative recovery management system can improve early recovery after lung cancer surgery. The AI-guided system is designed to integrate multiple types of patient-generated data, including patient-reported symptoms, vital signs, physical activity, respiratory rehabilitation completion, medication and nursing adherence, and, when needed, wound, drainage-site, or chest-related images or short videos. The system will provide postoperative recovery feedback, general nursing advice, respiratory rehabilitation reminders, activity guidance, symptom management suggestions, and risk stratification alerts. The AI system is not intended to diagnose postoperative complications, prescribe medication, recommend self-adjustment of prescription drugs, or replace the clinical judgment of physicians or nurses. For red-flag symptoms or high-risk conditions, the system will advise patients to contact the clinical team or seek medical care. Both study groups will retain access to usual clinical safety pathways throughout the trial. Participants will be randomly assigned in a 1:1 ratio to the AI-guided recovery management group or the usual postoperative care group. The AI-guided group will receive usual postoperative care plus the multimodal AI recovery management system from postoperative intervention initiation to postoperative day 30. The usual-care group will receive standard postoperative management, including routine inpatient care, pain management, respiratory exercise instruction, activity and diet advice, medication guidance, discharge education, outpatient follow-up arrangements, and routine telephone or online follow-up where applicable. To ensure consistent outcome measurement, participants in both groups will complete patient-reported symptom assessments at the same prespecified time points. The primary outcome is the number of MDASI-LC-derived target symptom threshold events per patient within 30 days after surgery. Target symptoms include pain, fatigue, disturbed sleep, shortness of breath, and cough. Each target symptom will be assessed using MDASI-LC items or equivalent 0-10 numeric rating scales. A target symptom threshold event is defined as any target symptom score of 4 or higher at a prespecified assessment time point. The study will also evaluate overall target symptom burden, postoperative quality of recovery, time to recovery to a mild-symptom state, MDASI-LC functional interference, adherence to respiratory rehabilitation exercises, adherence to physical activity recommendations, unplanned healthcare utilization, pulmonary complications, unplanned readmission, and AI-related safety and feasibility outcomes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
868
Participants in the conventional internet group will receive routine postoperative rehabilitation nursing and use conventional internet-based information resources for rehabilitation-related information after thoracic surgery.
Participants in the large language model-assisted rehabilitation nursing group will receive artificial intelligence-assisted postoperative rehabilitation nursing. The system will analyze postoperative patient data and generate individualized rehabilitation recommendations, including pain management, pulmonary function training, and exercise rehabilitation. The rehabilitation module will support digital entry and feedback of standardized scales and recovery-related information, including pain scores, activity monitoring, step count, symptom self-assessment, cough frequency, and dyspnea level. Healthcare professionals will remain responsible for clinical oversight and safety management.
the First Affiliated Hospital of Guangzhou Medical University, Guangzhou,Guangdong 510120
Guangzhou, Guangdong, China
RECRUITINGNumber of MDASI-LC-Derived Target Symptom Threshold Events Within 30 Days After Surgery
The outcome is the number of target symptom threshold events per patient from postoperative intervention initiation to postoperative day 30. Target symptoms include pain, fatigue, disturbed sleep, shortness of breath, and cough. Each target symptom will be assessed using MDASI-LC items or equivalent 0-10 numeric rating scales. A target symptom threshold event is defined as any target symptom score of 4 or higher at a prespecified assessment time point.
Time frame: From postoperative intervention initiation to postoperative day 30
Overall Target Symptom Burden Within 30 Days After Surgery
Overall target symptom burden will be assessed using MDASI-LC target symptom items, including pain, fatigue, disturbed sleep, shortness of breath, and cough. The outcome may be summarized as the mean score of the five target symptoms at each prespecified time point or as the area under the symptom burden curve over 30 days. Higher scores indicate greater symptom burden.
Time frame: From postoperative intervention initiation to postoperative day 30
Postoperative quality of recovery score
Postoperative quality of recovery will be assessed using the QoR-15 or QoR-40 questionnaire. The questionnaire evaluates domains such as pain, physical comfort, emotional state, physical independence, and psychological support. Higher scores indicate better postoperative recovery quality.
Time frame: Postoperative baseline, day 7, day 14, and day 30
Time to Recovery to a Mild-Symptom State
Time to recovery to a mild-symptom state is defined as the time from postoperative intervention initiation to the first day when all target symptom scores are below 4 and remain below 4 for at least 3 consecutive days. Target symptoms include pain, fatigue, disturbed sleep, shortness of breath, and cough.
Time frame: From postoperative intervention initiation to postoperative day 30
MDASI-LC Functional Interference Score
Functional interference will be assessed using MDASI-LC interference items. These items evaluate the extent to which postoperative symptoms interfere with daily function, including general activity, walking, work or household tasks, mood, relations with others, and enjoyment of life. Higher scores indicate greater functional interference.
Time frame: Postoperative baseline, day 7, day 14, and day 30
Adherence to Respiratory Rehabilitation Exercises
Adherence to respiratory rehabilitation exercises will be assessed as the proportion of prescribed or recommended respiratory training sessions completed by the patient. Exercises may include deep breathing, effective coughing, pursed-lip breathing, incentive spirometer training, or other center-specific postoperative pulmonary rehabilitation exercises.
Time frame: From postoperative intervention initiation to postoperative day 30
Adherence to Postoperative Physical Activity Recommendations
Adherence to postoperative physical activity recommendations will be assessed using patient self-report, smartphone step counts, wearable device records, or study logs, where available. Activities may include early ambulation, walking, home-based light physical activity, or achievement of prespecified daily step goals.
Time frame: From postoperative intervention initiation to postoperative day 30
Unplanned Healthcare Utilization Within 30 Days After Surgery
Unplanned healthcare utilization is defined as any unplanned healthcare contact related to postoperative recovery within 30 days after surgery. Events may include unplanned outpatient visits, urgent telephone or online consultations, emergency department visits, or unplanned hospital readmissions.
Time frame: Within 30 days after surgery
Pulmonary Complications and Unplanned Readmission Within 30 Days After Surgery
This outcome includes pulmonary complications and unplanned readmission within 30 days after surgery. Pulmonary complications may include pneumonia, atelectasis requiring clinical intervention, respiratory failure, need for noninvasive or invasive ventilation, clinically significant pleural effusion, pneumothorax requiring treatment, prolonged air leak, or other pulmonary complications recorded by the clinical team.
Time frame: Within 30 days after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.